BIRC5 and Merkel cell skin cancer: Consistent with prior reports of MCC dependency on survivin32, we found that pharmacological inhibition of survivin or its siRNA knockdown more potently reduced VP-MCC viability relative to VN-MCC (Supplementary Fig. S8A, C).